Results for Genetic Predisposition to Hematologic Malignancies

1 - 6 of 6

Dr. Olson aims to improve diagnostics and treatment of bone marrow failure (BMF) syndromes, and to improve clinical hematopoietic stem cell transplantation (HSCT) outcomes. He conducts clinical trials of HSCT for non-malignant hematologic diseases. His laboratory explores both basic and translational research focused on genomics of BMF and the impact of BMF on hematopoietic niche function during HSCT.

E-mail:

olsont [at] chop.edu

CHOP to Host ‘Personalizing Pediatric Cancer Care’ Summit

Published on

Jan 28, 2022

in Cornerstone Blog

CHOP to Host ‘Personalizing Pediatric Cancer Care’ Summit

World-class experts will gather at CHOP summit to present on scientific advances in pediatric cancer care in the diagnostics and therapeutic space.

Improving Outcomes in Pediatric Oncology: Q&A With Garrett Brodeur, MD

Published on

Jan 3, 2022

in Cornerstone Blog

Improving Outcomes in Pediatric Oncology

Congratulations to Garrett Brodeur, MD, recipient of the American Society of Pediatric Hematology/Oncology Distinguished Career Award.

Division of Oncology

Advancing state-of-the-art cancer investigation and care for children through a world-renowned, integrated basic, translational, and clinical research environment.

Comprehensive Bone Marrow Failure Center

The Comprehensive Bone Marrow Failure Center brings together physicians and researchers to provide state-of-the-art diagnostics, clinical care, and investigational studies, as well as basic research focused on acquired and inherited bone marrow failure.

Olson Laboratory

The Olson Lab aims to improve diagnostics and treatment of bone marrow failure (BMF) syndromes, and to improve clinical hematopoietic stem cell transplantation (HSCT) outcomes.